LLY241018P440000
- 0.42
- 0.000.00%
Eli Lilly and Co Newsroom
Eli Lilly (LLY): Revenue Boost From Zepbound and Mounjaro Amid Strong Market Projections
'FDA Won't Take Action Against GLP-1 Compounders As It Rethinks Tirzepatide Shortage' - Endpoints News
Behind the Scenes of Eli Lilly's Latest Options Trends
OAC and Eli Lilly and Company Partner to Launch Bias-Free Obesity Image Gallery at HLTH 2024
"Trump Trade" is restarting, what are the differences?
The new change of the "Trump trade" is that US technology stocks are more resilient, energy stocks are weaker, US bond yields are falling instead of rising, and gold is performing stronger. Ping An Securities believes that the current situation is still in a stalemate, and it is uncertain how far the "Trump trade" can go.
Leerink Partners Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $990
$1000 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today
Investors in Eli Lilly (NYSE:LLY) Have Seen Fantastic Returns of 814% Over the Past Five Years
Express News | Eli Lilly : Bernstein Initiates Coverage With Outperform Rating; Target Price $1,100
Trump, big comeback! Is the 'Trump trade' making a comeback?
"Trump trade" is gaining momentum. The long-dormant "Trump trade" seems to be making a comeback. Among them, the stock price of the Trump Media and Technology Group has been soaring, with the stock price skyrocketing over 15.5% on October 16th Eastern Time, a cumulative increase of over 166% compared to the September low. At the same time, the "Trump trade" is boosting the prices of bitcoin and the US dollar. On the news front, there has been a major turnaround in Trump's election prospects. As of October 16th local time, a latest nationwide poll released by Fox News shows Trump leading Harris by 50% to 48%, which is different from September.
No matter who takes over the White House, financial trading activities will pick up.
Whether it's Donald Trump or Kamala Harris taking office in the White House, the market generally expects financial trading activities to heat up, bringing good news to Citigroup, Goldman Sachs, JPMorgan, and other major banks.
Express News | According to the average of the betting market provided by the website RealClearPolitics that summarizes gambling odds, as of the evening of October 16th local time, Trump's chances of winning have reached 57.7%, the highest level since July 22, far ahead
Bernstein begins to focus on US pharmaceutical stocks, rating eli lilly and co (LLY.US) and others as "outperforming large cap".
Bernstein begins coverage of eli lilly and co (LLY.US), gilead sciences (GILD.US), and amgen (AMGN.US), all rated as "outperforming large cap".
Lilly, Gilead, Amgen Started at Outperform by Bernstein
Least Shorted S&P 500 Stocks in September
Lilly Confirms Date and Conference Call for Third-quarter 2024 Financial Results Announcement
Express News | Sunbird Bio: Raises $14 Mln, Backed by Eli Lilly and Strategic Investment Arm of Singapore Economic Development Board, Edbi
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
DBS Maintains Eli Lilly and Co(LLY.US) With Buy Rating
Survey Reveals 8 in 10 Americans With Ulcerative Colitis Struggle to Find a Public Restroom During Emergencies